QUIDELORTHO CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.98 USD | +1.82% |
|
+6.35% | -38.41% |
| 05-14 | Activist Jana Partners built position in QuidelOrtho in first quarter, sources say | RE |
| 05-14 | Sector Update: Health Care Stocks Rise in Late Afternoon Trading | MT |
Presenter SpeechRuben Argueta (Executives)Good morning, everyone. Thank you for joining us vir...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Calendar
31/07/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
44.18
USD
Average target price
51.4
USD
Spread / Average Target
+16.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.41% | 2.96B | |
| -12.09% | 19.25B | |
| +22.02% | 1.96B | |
| -0.62% | 1.69B | |
| +33.51% | 1.27B | |
| -16.17% | 982M | |
| -22.01% | 913M | |
| +5.38% | 801M | |
| -23.54% | 630M | |
| +8.96% | 506M |
- Stock Market
- Equities
- QDEL Stock
- News QuidelOrtho Corporation
- Transcript : Quidel Corporation - Analyst/Investor Day
